FAK inhibitor
-
Immune-based Therapy Shows Potential Against Pancreatic Cancer in Mouse Models
A new preclinical trial showed that FAK inhibitor used in conjunction with immunotherapy and chemotherapy can increase the survival rate of patients with advance pancreatic cancer.
Latest Research Articles
most popular
-
World’s Biggest Coral, Hidden Beneath Solomon Islands Waters, Revealed by Diver
-
Monkeypox Evolution Reaches Deadly Strain, Now Detected in US
-
How Climate Change Could Worsen Dengue Spread in Years to Come
-
Did Earth Have Saturn-like Rings Millions of Years Ago?
-
Global Plastic Pileup Could Be Halted With Four Policies, California Study Finds
